Seek Returns logo

ABT vs. GKOS: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ABT and GKOS, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

ABT dominates in value with a market cap of 231.49 billion USD, eclipsing GKOS’s 5.42 billion USD by roughly 42.72×.

With betas of 0.74 for ABT and 0.83 for GKOS, both show similar volatility profiles relative to the overall market.

SymbolABTGKOS
Company NameAbbott LaboratoriesGlaukos Corporation
CountryUSUS
SectorHealthcareHealthcare
IndustryMedical - DevicesMedical - Devices
CEOMr. Robert B. FordMr. Thomas William Burns
Price133.05 USD94.82 USD
Market Cap231.49 billion USD5.42 billion USD
Beta0.740.83
ExchangeNYSENYSE
IPO DateMarch 17, 1980June 25, 2015
ADRNoNo

Performance Comparison

This chart compares the performance of ABT and GKOS over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of ABT and GKOS based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • GKOS shows a negative P/E of -43.42, highlighting a year of losses, whereas ABT at 17.22 trades on solid profitability.
  • GKOS shows a negative forward PEG of -2.44, signaling expected earnings contraction, while ABT at 1.73 maintains analysts’ projections for stable or improved profits.
  • GKOS reports a negative Price-to-Free Cash Flow ratio of -101.77, showing a cash flow shortfall that could threaten its operational sustainability, while ABT at 34.77 maintains positive cash flow.
SymbolABTGKOS
Price-to-Earnings Ratio (P/E, TTM)17.22-43.42
Forward PEG Ratio (TTM)1.73-2.44
Price-to-Sales Ratio (P/S, TTM)5.4713.39
Price-to-Book Ratio (P/B, TTM)2.487.03
Price-to-Free Cash Flow Ratio (P/FCF, TTM)34.77-101.77
EV-to-EBITDA (TTM)22.97-67.34
EV-to-Sales (TTM)5.6313.37
EV-to-Free Cash Flow (TTM)35.78-101.60

Dividend Comparison

ABT delivers a 1.71% dividend yield, blending income with growth, whereas GKOS appears to retain its profits, possibly to fund operations, R&D, or other growth initiatives.

SymbolABTGKOS
Dividend Yield (TTM)1.71%0.00%

Financial Strength Metrics Comparison

This section dives into the financial resilience of ABT and GKOS, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • ABT meets its interest obligations (ratio 15.39). In stark contrast, GKOS’s negative ratio (-13.09) means its operating earnings (EBIT) don't cover basic operations, let alone interest, signaling serious financial trouble.
SymbolABTGKOS
Current Ratio (TTM)1.786.49
Quick Ratio (TTM)1.275.62
Debt-to-Equity Ratio (TTM)0.140.14
Debt-to-Assets Ratio (TTM)0.160.11
Interest Coverage Ratio (TTM)15.39-13.09